Compare, Analyse Procter & Gamble Health with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs TEVA PHARMA (Israel) - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PROCTER & GAMBLE HEALTH   TEVA PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
TEVA PHARMA
Dec-13
PROCTER & GAMBLE HEALTH/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,5493,131-   
Low Rs1,3012,720-   
Sales per share (Unadj.) Rs511.41,796.9-  
Earnings per share (Unadj.) Rs61.3112.2-  
Cash flow per share (Unadj.) Rs74.0257.5-  
Dividends per share (Unadj.) Rs440.0098.26-  
Dividend yield (eoy) %18.13.4 540.1%  
Book value per share (Unadj.) Rs927.81,996.0-  
Shares outstanding (eoy) m16.60848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.71.6 291.3%   
Avg P/E ratio x39.626.1 151.8%  
P/CF ratio (eoy) x32.811.4 288.4%  
Price / Book Value ratio x2.61.5 178.3%  
Dividend payout %717.987.5 820.1%   
Avg Mkt Cap Rs m40,2572,480,731 1.6%   
No. of employees `0001.144.9 2.5%   
Total wages/salary Rs m1,3130-   
Avg. sales/employee Rs Th7,486.733,902.6 22.1%   
Avg. wages/employee Rs Th1,157.60-   
Avg. net profit/employee Rs Th897.22,117.9 42.4%   
INCOME DATA
Net Sales Rs m8,4901,523,753 0.6%  
Other income Rs m2440-   
Total revenues Rs m8,7341,523,753 0.6%   
Gross profit Rs m1,482417,281 0.4%  
Depreciation Rs m211123,166 0.2%   
Interest Rs m029,929 0.0%   
Profit before tax Rs m1,514264,185 0.6%   
Minority Interest Rs m01,200 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m66-173,423 -0.0%   
Tax Rs m563-3,225 -17.4%   
Profit after tax Rs m1,01795,188 1.1%  
Gross profit margin %17.527.4 63.7%  
Effective tax rate %37.1-1.2 -3,042.5%   
Net profit margin %12.06.2 191.8%  
BALANCE SHEET DATA
Current assets Rs m15,3431,029,137 1.5%   
Current liabilities Rs m1,960897,495 0.2%   
Net working cap to sales %157.68.6 1,824.6%  
Current ratio x7.81.1 682.6%  
Inventory Days Days4991 53.7%  
Debtors Days Days2896 29.7%  
Net fixed assets Rs m1,209497,691 0.2%   
Share capital Rs m1663,751 4.4%   
"Free" reserves Rs m15,2350-   
Net worth Rs m15,4011,692,601 0.9%   
Long term debt Rs m0779,129 0.0%   
Total assets Rs m17,5953,482,264 0.5%  
Interest coverage xNM9.8-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.50.4 110.3%   
Return on assets %5.83.6 160.9%  
Return on equity %6.65.6 117.5%  
Return on capital %10.34.9 208.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,7320-   
CASH FLOW
From Operations Rs m-1,304242,807 -0.5%  
From Investments Rs m12,697-86,036 -14.8%  
From Financial Activity Rs m-301-291,264 0.1%  
Net Cashflow Rs m11,093-134,493 -8.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.01 Rs / USD

Compare PROCTER & GAMBLE HEALTH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare PROCTER & GAMBLE HEALTH With: STERLING BIOTECH  NEULAND LABS  GSK PHARMA  PANACEA BIOTECH  TTK HEALTHCARE  



Today's Market

Sensex Zooms 661 Points, Nifty Ends Above 14,500; M&M and Bajaj Finserv Top Gainers(Closing)

Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.

Related Views On News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY21); Net Profit Up 57.0% (Quarterly Result Update)

Aug 31, 2020 | Updated on Aug 31, 2020

For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This... (Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

The Indian Real Estate Party Has Just Begun (Profit Hunter)

Apr 1, 2021

A favourable demand supply scenario makes a strong case for real estate prices.

The Dilemma of Investing in Bharti Airtel Views On News (Views On News)

Apr 1, 2021

Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

PROCTER & GAMBLE HEALTH SHARE PRICE


Apr 13, 2021 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 5-YR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS